These benefits, along with a previous report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 support the strategy of focusing on ACKR3 as a singular solution to modulate the opioid program, which could open new therapeutic avenues for opioid-linked Conditions. In combination with the described https://hansl923slr3.wikiinside.com/user